Hmm, I mean I'll post up on longbets - sure.
Terafab profitability is really tough to get right, I'm open to ideas -- there's operating profit, operating profit net of amortization / depreciation, there's like six phases of the terafab specced out running through 203X (and as you say, slippage is inevitable there). I'd want to be considered a winner if the value of the EUV machines is up significantly, e.g. it was a balance sheet winner.
Send proposals.